Annual Meeting 2018   |   ASGCT News

ASGCT 2018 Election Results

ASGCT Staff - April 23, 2018

Four elected members join the Board of Directors at the 21st Annual Meeting.

After a monthlong election, members of the American Society of Gene & Cell Therapy have elected four new members to the Society's Board of Directors, including a new incoming vice president.

Each elected member will serve a three-year term, including the incoming vice president who will enter the leadership succession line. Stephen Russell, MD, PhD will serve a yearlong term as vice president before serving as ASGCT's president-elect and, finally, president through the 2021 annual meeting.

All four of the following newly-elected members will begin their terms on the Board of Directors during the 21st Annual Meeting next month at the Hilton Chicago:

Vice President

Stephen Russell, MD, PhD
Mayo Clinic

Translational and Clinical Development Representative

Richard Morgan, PhD
bluebird bio

At-Large Director

Jennifer Adair, PhD
Fred Hutchinson Cancer Research Center

At-Large Director

Stephen Hart, PhD
UCL Great Ormond Street Institute of Child Health


Congratulations to the incoming members of the ASGCT Board of Directors!

Share This Page

Related Articles

ASGCT News

ASGCT Education Program Returns, Covers Parkinson's Disease

ASGCT Staff - October 10, 2019
ASGCT News

Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles

ASGCT Staff - June 26, 2019
Advocacy

ASGCT Heats Up in Summer 2019

Maritza McIntyre, Ph.D. - June 14, 2019
Annual Meeting 2019

FDA Approves Zolgensma, Landmark AAV-Delivered Gene Therapy to Treat Spinal Muscular Atrophy

May 24, 2019